Fempatch side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Fempatch. Common side effects include aphasia among females.
The phase IV clinical study is created by eHealthMe based on 15 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
15 people who take Fempatch and have side effects are studied.
What is Fempatch?
Fempatch has active ingredients of estradiol. Currently, eHealthMe is studying from 17 Fempatch users.
Number of Fempatch reports submitted per year:

Fempatch side effects by gender *:
female:
- Aphasia (damage to the parts of the brain that control language)
- Ovarian cancer (cancer of ovary)
- Alanine aminotransferase increased
- Aldolase increased
- Breast cancer
- Breast cancer female
- Eye pain
- Skin irritation
male:
n/a
Fempatch side effects by age (0-1 to 60+) *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Alanine aminotransferase increased
- Aldolase increased
- Breast cancer
- Breast cancer female
- Eye pain
60+:
- Skin irritation
* Approximation only. Some reports may have incomplete information.
Do you take Fempatch?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on estradiol (the active ingredients of Fempatch) and Fempatch (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Fempatch:
- Fempatch (17 reports)
All Fempatch side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Garcinia Cambogi and Heparin drug interaction - 11 seconds ago
- Glucophage and Tendonitis - 12 seconds ago
- Claforan and Imodium drug interaction - 14 seconds ago
- Delsym and Gastric Ulcer - 14 seconds ago
- Tamsulosin and Renflexis drug interaction - 15 seconds ago
- Bactrim Ds and Stavudine drug interaction - 16 seconds ago
- Vraylar and Depo-Provera drug interaction - 18 seconds ago
- Zaleplon and Swelling - 30 seconds ago
- Novolog and Plantar Fasciitis - 31 seconds ago
- Locoid and Rash Papular - 33 seconds ago